Form 4: Azenta CEO John Marotta Receives RSU Grant

Azenta, Inc. CEO John Marotta was granted 122,269 restricted stock units, increasing his beneficial ownership to 217,268.78 shares.

Summary

• John Marotta, President and CEO, and a Director of Azenta, Inc. (AZTA), was granted 122,269 shares of common stock in the form of Restricted Stock Units (RSUs).
• The transaction date for this grant was November 24, 2025.
• No amount was paid upon the grant of these RSUs, as the number was determined by dividing a target award value by the average closing price of the company's common stock over 20 trading days ending on the grant date.
• Following this transaction, John Marotta beneficially owns a total of 217,268.78 shares of Azenta, Inc. common stock.
• The RSUs are subject to time-based vesting, with 33-1/3% vesting per year, commencing on November 24, 2026.

Sentiment

Score: 6

Explanation: The RSU grant is a routine executive compensation event, generally viewed as neutral to slightly positive as it aligns management's interests with shareholders over the long term. It does not indicate any immediate operational or financial changes.

Positives

• The grant of Restricted Stock Units (RSUs) aligns the CEO's long-term interests with those of shareholders, as the value of the compensation is tied to the company's stock performance.
• This is a standard form of executive compensation, indicating a structured approach to incentivizing leadership.

Risks

• The value of the RSU grant is dependent on the future performance of Azenta, Inc.'s common stock price.
• The RSUs are subject to time-based vesting, meaning the full benefit is contingent on John Marotta's continued employment with the company through the vesting periods.

Future Outlook

The RSU grant indicates a future alignment of the CEO's compensation with the company's long-term performance, with vesting scheduled annually starting in November 2026.

Industry Context

The grant of Restricted Stock Units (RSUs) to a President and CEO is a common and widely accepted practice in the U.S. corporate landscape for executive compensation. It serves to attract, retain, and motivate key leadership by linking their personal wealth creation directly to the company's stock performance over a multi-year period, a standard across various industries for aligning management incentives with shareholder value.

Comparison to Industry Standards

• The use of Restricted Stock Units (RSUs) as a component of executive compensation is a standard practice across publicly traded companies, comparable to compensation structures at peers like Thermo Fisher Scientific (TMO) or Danaher Corporation (DHR) in the life sciences tools and services sector.
• The time-based vesting schedule of 33-1/3% per year over three years is a typical vesting structure, similar to those observed in executive equity grants at companies such as Illumina (ILMN) or Bio-Rad Laboratories (BIO), designed to promote long-term retention and performance.

Related Party Transactions

• The grant of Restricted Stock Units to John Marotta, the President and CEO, constitutes a transaction between the company and a related party.

Stakeholder Impact

• Shareholders: The RSU grant aims to align the CEO's financial incentives with long-term shareholder value creation, potentially leading to more focused strategic decisions.
• Employees: Standard executive compensation practices can influence overall company morale and perception of fairness in compensation structures.

Next Steps

• The granted RSUs will begin to vest on November 24, 2026, at a rate of 33-1/3% per year.

Key Dates

Recommendation

This Form 4 filing reports a routine executive compensation event (RSU grant) and does not provide new information that would fundamentally alter the investment thesis for Azenta, Inc. While it indicates management alignment, it is not a catalyst for a 'buy' or 'sell' recommendation based solely on this filing. Investors should 'hold' and consider broader company fundamentals and market conditions.

Keywords

Azenta, AZTA, Form 4, RSU, Restricted Stock Units, Executive Compensation, Insider Transaction, John Marotta, Equity Grant